Truist reiterates Buy on Community Healthcare Trust stock after earnings beat

Truist Securities has reaffirmed its Buy rating and $17.00 price target for Community Healthcare Trust (NYSE:CHCT) following the company's strong third-quarter earnings release. The real estate investment trust reported better-than-expected funds from operations of $0.54 per share, marking an 8.2% year-over-year increase. This surpassed Truist's estimate and the consensus expectation of $0.48 per share by $0.06.

The improved results were primarily due to a rise in portfolio occupancy, which increased by 30 basis points quarter-over-quarter. Additionally, the company experienced a decline in deferred compensation expenses by $0.9 million from the prior quarter.

Community Healthcare Trust's current market capitalization is $353 million, with a P/E ratio of 19.73 and a dividend yield of 10.11%. Notably, the stock has underperformed by 14% year-to-date, in contrast to the positive 14% return of the FTSE NAREIT All Equity REIT Index. Despite this recent underperformance, InvestingPro data indicates that the stock is currently undervalued and is featured on the platform's most undervalued stocks list.

Moreover, the company has raised its dividend for 11 consecutive years, showcasing a commitment to returning value to shareholders.

Truist Securities highlighted that Community Healthcare Trust's acquisition pipeline remains strong, with high yields expected. The firm also noted that occupancy should improve further, and a transition related to Assurance Health seems likely. As investors closely monitor the company's performance, Truist recently held virtual meetings with the company's CEO and CFO, leading to a reduction of the stock's price target from $18.00 to $17.00.

All of these developments are taking place as the company navigates a challenging financial environment, prompting analysts to keep a close eye on its progress.